US 7323616
Genetically altered mice deficient in functional caspase-9
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 7323616 (Genetically altered mice deficient in functional caspase-9) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61P, A61P43/00